In this issue:
Clinical outcomes in COVID-19 patients taking a TNFi or methotrexate
Chilblains and COVID-19
Association of the psoriatic microenvironment with treatment response
Clearance of moderate-tosevere plaque psoriasis with biologics in a real world setting
TNFi-induced psoriasis
Ustekinumab treatment and early severe cardiovascular events
Drug-induced lupus erythematosus
Finasteride and suicide
Pigmented purpuric dermatosis in children
Incomplete primary excision of BCCs
Please login below to download this issue (PDF)